Verve Medical

Phoenix, AZ · Founded 2010 · Privately Held (backing)

Developer of renal denervation devices intended to reduce hypertension. Verve Medical is based in Phoenix, AZ and was founded in 2010. It was valued at $64 million at its later-stage round in Aug 2020, the last priced event on record. It has raised $11.2 million across 2 recorded rounds; the latest was a $470,000 seed round in Oct 2016.

PMV mark · valuation
$64.0M
Oct 2026
Priced at
its later-stage round
Aug 2020
Total raised
$11.2M
Last round
Seed Round
Oct 2016
What is Verve Medical worth?
$64.0MPrivateMarketView mark · Oct 2026

Valued at $64.0M at its later-stage round, Aug 2020. Nothing has traded since.

Free account
More of Verve Medical with a free account
  • ·Watch Verve Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Verve Medical funding history

2 rounds
DateRoundRaisedPost-money
Oct 2016Seed Round$470K▮
Dec 2014Seed Round$1.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Verve Medical valuation

Verve Medical was valued at $64 million at its later-stage round in Aug 2020. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Verve Medical raised?

Verve Medical has raised $11.2 million in total; 2 of its rounds are on record. The largest on record was a $470,000 seed round in Oct 2016.

Verve Medical has filed 3 Form Ds with the SEC since 2015, most recently in Jan 2017 ($470,000 sold to 5 investors).

How Verve Medical's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Verve Medical, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Verve Medical

What is Verve Medical worth?
Verve Medical is valued at $64.0M as of Oct 2026. Valued at $64.0M at its later-stage round, Aug 2020. Nothing has traded since.
How much has Verve Medical raised?
Verve Medical has raised $11.2M in total funding across 2 recorded rounds.
When did Verve Medical last raise?
Verve Medical last raised in Oct 2016 (Seed Round), raising $470K.